Literature DB >> 14610103

The immunogenicity of biopharmaceuticals.

Huub Schellekens1.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 14610103     DOI： 10.1212/01.wnl.0000092358.51502.c0

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  5 in total

1.  Neutralizing antibodies against interferon-Beta.

Authors:  Per Soelberg Sorensen
Journal:  Ther Adv Neurol Disord       Date:  2008-09       Impact factor: 6.570

2.  Investigation of the immunogenicity of different types of aggregates of a murine monoclonal antibody in mice.

Authors:  Angelika J Freitag; Maliheh Shomali; Stylianos Michalakis; Martin Biel; Michael Siedler; Zehra Kaymakcalan; John F Carpenter; Theodore W Randolph; Gerhard Winter; Julia Engert
Journal:  Pharm Res       Date:  2014-08-15       Impact factor: 4.200

3.  Monocyte NOTCH2 expression predicts IFN-β immunogenicity in multiple sclerosis patients.

Authors:  Marsilio Adriani; Petra Nytrova; Cyprien Mbogning; Signe Hässler; Karel Medek; Poul Erik H Jensen; Paul Creeke; Clemens Warnke; Kathleen Ingenhoven; Bernhard Hemmer; Claudia Sievers; Raija Lp Lindberg Gasser; Nicolas Fissolo; Florian Deisenhammer; Zsolt Bocskei; Vincent Mikol; Anna Fogdell-Hahn; Eva Kubala Havrdova; Philippe Broët; Pierre Dönnes; Claudia Mauri; Elizabeth C Jury
Journal:  JCI Insight       Date:  2018-06-07

4.  Quantification of the neutralization of cytokine biological activity by antibody: the ten-fold reduction bioassay of interleukin-6 as growth factor.

Authors:  Sidney E Grossberg; Monika Casey; Leslie D Grossberg
Journal:  J Interferon Cytokine Res       Date:  2009-08       Impact factor: 2.607

5.  Influence of antidrug antibodies on plectasin efficacy and pharmacokinetics.

Authors:  Karoline Sidelmann Brinch; Niels Frimodt-Møller; Niels Høiby; Hans-Henrik Kristensen
Journal:  Antimicrob Agents Chemother       Date:  2009-08-17       Impact factor: 5.191
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.